Condition
Neurodegeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Neurodegeneration clinical trials that are recruiting, at sites in 4 countries (most in China (2), United Kingdom (2), United States (2)). By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Neurodegeneration clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How moderate wine drinking affects healthy aging through post-meal extracellular vesicles | — | Seville, Sevilla | Recruiting | Jan 23, 2026 |
| Kisspeptin to measure GnRH neuron function in people with and without post-COVID-19 syndrome | Phase 1 | Boston, Massachusetts | Recruiting | Nov 4, 2025 |
| Evaluating Tau PET/CT for Diagnosing Tau-Related Diseases | — | Hefei, Anhui and 2 other locations | Recruiting | Nov 15, 2024 |
| Comparing different exercise volumes for veterans with moderate Parkinson's disease | — | Decatur, Georgia | Recruiting | Oct 18, 2023 |
| Understanding serotonin release in Parkinson's disease | — | Exeter, Devon | Recruiting | Aug 26, 2022 |
| Investigating biomarkers for Parkinson's disease using advanced imaging techniques | — | Exeter, Devon | Recruiting | Aug 26, 2022 |
| Longitudinal study on aging and cognitive impairment in China | — | Hangzhou, Zhejiang and 1 other locations | Recruiting | Jul 21, 2022 |
All recruiting trials (7)
-
How moderate wine drinking affects healthy aging through post-meal extracellular vesicles
This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.
-
Kisspeptin to measure GnRH neuron function in people with and without post-COVID-19 syndrome
We will give one intravenous kisspeptin dose and take frequent blood samples to see if people with post-COVID-19 syndrome have different GnRH/LH hormone responses than people who had COVID but did not develop long COVID.
-
Evaluating Tau PET/CT for Diagnosing Tau-Related Diseases
This study is testing a new type of imaging scan to see if it can help doctors better diagnose Tau-related diseases in adults with suspected or diagnosed tumors.
-
Comparing different exercise volumes for veterans with moderate Parkinson's disease
This study is testing whether veterans with moderate Parkinson's disease benefit more from high-volume dance exercise or moderate-volume walking to improve their physical activity and walking speed.
-
Understanding serotonin release in Parkinson's disease
This study is trying to find a way to see changes in the brain of people with Parkinson's disease to help develop new treatments that could slow down the symptoms.
-
Investigating biomarkers for Parkinson's disease using advanced imaging techniques
This study is trying to find a marker for Parkinson's disease by using advanced brain scans to see how the disease affects brain chemistry and structure over time.
-
Longitudinal study on aging and cognitive impairment in China
This study is trying to understand how aging affects thinking skills and memory in different groups of people in China, including those with normal aging and various levels of cognitive impairment, by following them for up to five years.
Related topics
Quick answers
How many Neurodegeneration clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), United Kingdom (2 trials), United States (2 trials), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.